(Q46492805)

22 December 2017

title

Reduction of chronic allograft nephropathy by inhibition of extracellular signal-regulated kinase 1 and 2 signaling (English)

1 reference

22 December 2017

chronic allograft nephropathy

main subject

1 reference

Shuang Wang

1

1 reference

22 December 2017

Jifu Jiang

2

1 reference

22 December 2017

Qiunong Guan

3

1 reference

22 December 2017

Hao Wang

4

1 reference

22 December 2017

Christopher Y C Nguan

5

1 reference

22 December 2017

Anthony M Jevnikar

6

1 reference

22 December 2017

Caigan Du

7

1 reference

22 December 2017

publication date

9 July 2008

1 reference

22 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

22 December 2017

volume

295

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

F672-9

1 reference

22 December 2017

CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

TGF-beta signaling in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Renal tubular epithelial cell self-injury through Fas/Fas ligand interaction promotes renal allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Synergistic activation of signalling to extracellular signal-regulated kinases 1 and 2 by epidermal growth factor and 4 beta-phorbol 12-myristate 13-acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

PDGF-BB enhances alpha1beta1 integrin-mediated activation of the ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Adoptive transfer of primed CD4+ T-lymphocytes induces pattern of chronic allograft nephropathy in a nude rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

A study of the quality of life and cost-utility of renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta1 stimulated glomerular podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Therapeutic targets in the treatment of allograft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

TGF-beta signal transduction and mesangial cell fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Why hasn't eliminating acute rejection improved graft survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

The aetiology and pathogenesis of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

Chronic rejection of mouse kidney allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90285.2008

10.1152/AJPRENAL.90285.2008

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017